(MNST) Monster Beverage - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US61174X1090
Stock: Energy, Drinks, Alcohol, Water, Coffee
Total Rating 65
Risk 96
Buy Signal 0.90
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 22.6% |
| Relative Tail Risk | -7.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.47 |
| Alpha | 71.05 |
| Character TTM | |
|---|---|
| Beta | 0.317 |
| Beta Downside | 0.180 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.04% |
| CAGR/Max DD | 0.66 |
Description: MNST Monster Beverage January 29, 2026
Monster Beverage Corp. (NASDAQ: MNST) develops, markets, and distributes a broad portfolio of energy-drink and functional-beverage products worldwide, organized into four segments: Monster Energy Drinks, Strategic Brands, Alcohol Brands, and Other. Its lineup spans carbonated and non-carbonated energy drinks, ready-to-drink teas, coffees, juices, hard seltzers, and craft beers, sold through bottlers, retailers, food-service outlets, e-commerce platforms, and the U.S. military.
Key recent metrics (FY 2025): revenue $5.6 billion (+7 % YoY), adjusted EBITDA margin 28 %, net income $1.1 billion, and diluted EPS $2.85. The Monster Energy segment still drives ~75 % of sales, but the Alcohol Brands segment grew 23 % YoY, reflecting strong demand for hard seltzers and craft-beer extensions. Industry-wide, functional-beverage volume in the U.S. rose 4.5 % in 2025, while discretionary spending pressure from inflation has modestly slowed growth in lower-priced categories, favoring premium-priced energy and alcohol-blend products.
For a deeper, data-driven valuation of MNST, you may find ValueRay’s analytical tools useful for extending this snapshot.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.73b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 0.67 > 1.0 |
| NWC/Revenue: 43.58% < 20% (prev 35.79%; Δ 7.79% < -1%) |
| CFO/TA 0.23 > 3% & CFO 2.18b > Net Income 1.73b |
| Net Debt (-2.29b) to EBITDA (2.37b): -0.97 < 3 |
| Current Ratio: 3.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (985.0m) vs 12m ago 0.18% < -2% |
| Gross Margin: 55.81% > 18% (prev 0.54%; Δ 5528 % > 0.5%) |
| Asset Turnover: 90.30% > 50% (prev 92.02%; Δ -1.72% > 0%) |
| Interest Coverage Ratio: 135.9 > 6 (EBITDA TTM 2.37b / Interest Expense TTM 16.7m) |
Altman Z'' 10.00
| A: 0.36 (Total Current Assets 5.07b - Total Current Liabilities 1.59b) / Total Assets 9.61b |
| B: 0.93 (Retained Earnings 8.91b / Total Assets 9.61b) |
| C: 0.26 (EBIT TTM 2.27b / Avg Total Assets 8.83b) |
| D: 4.72 (Book Value of Equity 8.82b / Total Liabilities 1.87b) |
| Altman-Z'' Score: 12.08 = AAA |
Beneish M -2.97
| DSRI: 1.16 (Receivables 1.60b/1.29b, Revenue 7.98b/7.41b) |
| GMI: 0.96 (GM 55.81% / 53.77%) |
| AQI: 0.91 (AQ_t 0.36 / AQ_t-1 0.39) |
| SGI: 1.08 (Revenue 7.98b / 7.41b) |
| TATA: -0.05 (NI 1.73b - CFO 2.18b) / TA 9.61b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of MNST shares?
As of February 09, 2026, the stock is trading at USD 82.54 with a total of 4,292,714 shares traded.
Over the past week, the price has changed by +1.78%, over one month by +7.75%, over three months by +17.86% and over the past year by +72.64%.
Over the past week, the price has changed by +1.78%, over one month by +7.75%, over three months by +17.86% and over the past year by +72.64%.
Is MNST a buy, sell or hold?
Monster Beverage has received a consensus analysts rating of 3.76.
Therefor, it is recommend to hold MNST.
- StrongBuy: 10
- Buy: 3
- Hold: 9
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the MNST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 80.6 | -2.4% |
| Analysts Target Price | 80.6 | -2.4% |
| ValueRay Target Price | 103.9 | 25.9% |
MNST Fundamental Data Overview February 07, 2026
P/E Trailing = 46.6328
P/E Forward = 36.2319
P/S = 10.1116
P/B = 10.3124
P/EG = 1.9875
Revenue TTM = 7.98b USD
EBIT TTM = 2.27b USD
EBITDA TTM = 2.37b USD
Long Term Debt = 374.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 16.7m USD (from shortTermDebt, last fiscal year)
Debt = 374.0m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -2.29b USD (from netDebt column, last quarter)
Enterprise Value = 78.44b USD (80.64b + Debt 374.0m - CCE 2.58b)
Interest Coverage Ratio = 135.9 (Ebit TTM 2.27b / Interest Expense TTM 16.7m)
EV/FCF = 39.93x (Enterprise Value 78.44b / FCF TTM 1.96b)
FCF Yield = 2.50% (FCF TTM 1.96b / Enterprise Value 78.44b)
FCF Margin = 24.63% (FCF TTM 1.96b / Revenue TTM 7.98b)
Net Margin = 21.65% (Net Income TTM 1.73b / Revenue TTM 7.98b)
Gross Margin = 55.81% ((Revenue TTM 7.98b - Cost of Revenue TTM 3.52b) / Revenue TTM)
Gross Margin QoQ = 55.73% (prev 55.71%)
Tobins Q-Ratio = 8.16 (Enterprise Value 78.44b / Total Assets 9.61b)
Interest Expense / Debt = 0.13% (Interest Expense 500.0k / Debt 374.0m)
Taxrate = 23.94% (165.1m / 689.5m)
NOPAT = 1.73b (EBIT 2.27b * (1 - 23.94%))
Current Ratio = 3.19 (Total Current Assets 5.07b / Total Current Liabilities 1.59b)
Debt / Equity = 0.05 (Debt 374.0m / totalStockholderEquity, last quarter 7.75b)
Debt / EBITDA = -0.97 (Net Debt -2.29b / EBITDA 2.37b)
Debt / FCF = -1.17 (Net Debt -2.29b / FCF TTM 1.96b)
Total Stockholder Equity = 6.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.55% (Net Income 1.73b / Total Assets 9.61b)
RoE = 25.20% (Net Income TTM 1.73b / Total Stockholder Equity 6.85b)
RoCE = 31.41% (EBIT 2.27b / Capital Employed (Equity 6.85b + L.T.Debt 374.0m))
RoIC = 24.68% (NOPAT 1.73b / Invested Capital 7.00b)
WACC = 7.05% (E(80.64b)/V(81.02b) * Re(7.08%) + D(374.0m)/V(81.02b) * Rd(0.13%) * (1-Tc(0.24)))
Discount Rate = 7.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -3.26%
[DCF Debug] Terminal Value 84.07% ; FCFF base≈1.82b ; Y1≈2.17b ; Y5≈3.45b
Fair Price DCF = 76.51 (EV 72.46b - Net Debt -2.29b = Equity 74.75b / Shares 977.0m; r=7.05% [WACC]; 5y FCF grow 21.02% → 2.90% )
EPS Correlation: -52.54 | EPS CAGR: -50.47% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.78 | Revenue CAGR: 12.24% | SUE: 1.52 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.53 | Chg30d=+0.004 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=2.25 | Chg30d=+0.032 | Revisions Net=+3 | Growth EPS=+14.5% | Growth Revenue=+9.4%
P/E Forward = 36.2319
P/S = 10.1116
P/B = 10.3124
P/EG = 1.9875
Revenue TTM = 7.98b USD
EBIT TTM = 2.27b USD
EBITDA TTM = 2.37b USD
Long Term Debt = 374.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 16.7m USD (from shortTermDebt, last fiscal year)
Debt = 374.0m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -2.29b USD (from netDebt column, last quarter)
Enterprise Value = 78.44b USD (80.64b + Debt 374.0m - CCE 2.58b)
Interest Coverage Ratio = 135.9 (Ebit TTM 2.27b / Interest Expense TTM 16.7m)
EV/FCF = 39.93x (Enterprise Value 78.44b / FCF TTM 1.96b)
FCF Yield = 2.50% (FCF TTM 1.96b / Enterprise Value 78.44b)
FCF Margin = 24.63% (FCF TTM 1.96b / Revenue TTM 7.98b)
Net Margin = 21.65% (Net Income TTM 1.73b / Revenue TTM 7.98b)
Gross Margin = 55.81% ((Revenue TTM 7.98b - Cost of Revenue TTM 3.52b) / Revenue TTM)
Gross Margin QoQ = 55.73% (prev 55.71%)
Tobins Q-Ratio = 8.16 (Enterprise Value 78.44b / Total Assets 9.61b)
Interest Expense / Debt = 0.13% (Interest Expense 500.0k / Debt 374.0m)
Taxrate = 23.94% (165.1m / 689.5m)
NOPAT = 1.73b (EBIT 2.27b * (1 - 23.94%))
Current Ratio = 3.19 (Total Current Assets 5.07b / Total Current Liabilities 1.59b)
Debt / Equity = 0.05 (Debt 374.0m / totalStockholderEquity, last quarter 7.75b)
Debt / EBITDA = -0.97 (Net Debt -2.29b / EBITDA 2.37b)
Debt / FCF = -1.17 (Net Debt -2.29b / FCF TTM 1.96b)
Total Stockholder Equity = 6.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.55% (Net Income 1.73b / Total Assets 9.61b)
RoE = 25.20% (Net Income TTM 1.73b / Total Stockholder Equity 6.85b)
RoCE = 31.41% (EBIT 2.27b / Capital Employed (Equity 6.85b + L.T.Debt 374.0m))
RoIC = 24.68% (NOPAT 1.73b / Invested Capital 7.00b)
WACC = 7.05% (E(80.64b)/V(81.02b) * Re(7.08%) + D(374.0m)/V(81.02b) * Rd(0.13%) * (1-Tc(0.24)))
Discount Rate = 7.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -3.26%
[DCF Debug] Terminal Value 84.07% ; FCFF base≈1.82b ; Y1≈2.17b ; Y5≈3.45b
Fair Price DCF = 76.51 (EV 72.46b - Net Debt -2.29b = Equity 74.75b / Shares 977.0m; r=7.05% [WACC]; 5y FCF grow 21.02% → 2.90% )
EPS Correlation: -52.54 | EPS CAGR: -50.47% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.78 | Revenue CAGR: 12.24% | SUE: 1.52 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.53 | Chg30d=+0.004 | Revisions Net=-1 | Analysts=7
EPS next Year (2026-12-31): EPS=2.25 | Chg30d=+0.032 | Revisions Net=+3 | Growth EPS=+14.5% | Growth Revenue=+9.4%